Thomson Instrument Company Announces New Brand, Thomson Life Sciences, and Strategic Investment from Telegraph Hill Partners

Investment will support expanded manufacturing capabilities, faster commercialization, and continued growth across life science markets

CARLSBAD, Calif. - October 30, 2026 - Thomson Instrument Company today announced the launch of its new customer-facing brand, Thomson Life Sciences, together with a strategic investment from Telegraph Hill Partners (THP). These milestones mark an important next step in the company's growth and reflect its expanding role in supporting life science workflows.

The Thomson Life Sciences name better represents the company's growing portfolio of laboratory and bioprocess solutions for biopharmaceutical, biotechnology, and research organizations. Its solutions support plasmid production, cell culture, clarification, analytical sample preparation, and laboratory automation.

THP's investment will support additional product development initiatives, expanded manufacturing capabilities, increased production capacity, and faster commercialization of new laboratory and bioprocess solutions.

“Thomson has built a strong foundation of innovative products and longstanding relationships across the life sciences industry. This partnership gives us additional resources and expertise to expand our manufacturing capabilities, bring new technologies to customers faster, and accelerate our growth. Our new name reflects the broader role we are playing in helping customers improve laboratory and bioprocess workflows.”
- Sam Ellis, Chief Executive Officer, Thomson Life Sciences

“Thomson has developed differentiated technologies that address important and growing needs across the life sciences industry. We see significant opportunities to expand the company's market presence and bring its innovative solutions to a broader customer base. We are excited to partner with the Thomson team in this next phase of growth.”
- Dr. Paul Grossman, Partner, Telegraph Hill Partners

The new brand and THP partnership position Thomson for its next stage of growth while preserving the commitment customers know and trust: practical, innovative solutions backed by scientific credibility and reliable support.

For customers, the transition is straightforward. Thomson Instrument Company remains the underlying legal entity, doing business as Thomson Life Sciences. Existing customer agreements, quotes, vendor records, and other legal documentation are not expected to require changes. Customers may see both names as materials and systems are updated.